We report a case of cutaneous vasculopathy associated with the use of levamisoleadulterated cocaine. This recently described clinical entity is characterized by a purpuric rash with a predilection for the ears, leukopenia and ANCA positivity. It is estimated that more than 70% of the current US cocaine supply is contaminated with levamisole. Levamisole is a widely available, inexpensive white powder used as a "cutting agent" in cocaine to expand volume and increase profits. It may also increase the euphoric and stimulatory effects of cocaine by increasing brain dopamine levels and producing amphetamine-like metabolites. Our patient exhibited a characteristic rash with involvement of the ears, leukopenia, and cocaine metabolites detected in serum and urine; the presence of levamisole was confirmed in the urine utilizing gas chromatography -mass spectrometry. ANCA positivity was also present.
Approximately one year prior to the current presentation, the patient was admitted for a similar rash which was present on his ears, elbows, legs and trunk. At that time the rash was described as macular, violaceous and non-blanching, with areas of central necrosis. Tests for rheumatoid factor, cryoglobulin and anti-nuclear antibody (ANA) were negative. C3 and C4
were within normal range (65 mg/dL and 14 mg/dL, respectively). Enzyme linked immunosorbent assay (ELISA) for anti-proteinase 3 anti-neutrophil cytoplasmic antibodies (PR3-ANCA) was positive at 43 AU/ml (normal 0-19 AU/ml). ELISA for anti-myeloperoxidase (MPO-ANCA) was also mildly positive at 22 AU/ml (normal 0-19 AU/ml), which became negative on repeat testing, as skin lesions improved. IgM anti-cardiolipin antibody was 35 MPL U/ml (normal 0-12 MPL/ml). Lupus-like anticoagulant was weakly positive. Testing for Human Immunodeficiency virus, Parvovirus, Cytomegalovirus, and Ebstein-Barr virus were all negative.
The cocaine metabolite, benzoylecgonine, was detected inurine. A punch biopsy of the lesion over the patient's elbow demonstrated microthrombi with overlying epidermal necrosis ( Figure   2a and 2b). The patient was treated with high dose prednisone (1mg/kg/day) for 2 months which was tapered to a dose of 15mg/day. The rash on his trunk and extremities improved while the rash on the earlobes completely resolved. Prednisone was discontinued 5 months prior to this present emergency room encounter. The patient reported cessation of cocaine use during that same time period.
DISCUSSION
The differential diagnosis of retiform purpura, which is characterized by stellate or branching purpuric lesions, is extensive and includes small and medium-sized vessel vasculitis, infectious and embolic phenomenon, warfarin skin necrosis, disseminated intravascular coagulation, cryoglobulinemia and anti-phospholipid antibody syndrome. In users of cocaine contaminated with levamisole, a cutaneous vasculopathy syndrome has recently emerged and is characterized by a distinctive purpuric rash with a predilection for the ears, ANCA positivity, and leukopenia. [1] [2] [3] Levamisole, an antihelminthic with immunomodulatory properties, was previously used for the treatment of autoimmune disorders, pediatric nephritic syndrome and cancer. It was withdrawn from the market in 2000 due to its adverse side effect profile, specifically agranulocytosis. Levamisole is now found as an adulterant in as much as 70%-88% of cocaine in the United States. 4, 5 Levamisole is a widely available, inexpensive white powder which is used as a "cutting agent" in cocaine to expand volume and increase profits. Levamisole may also increase the euphoric and stimulatory effects of cocaine by increasing brain dopamine levels and producing amphetamine-like metabolites. 6 Cutaneous manifestations associated with levamisole use are varied and include nonspecific eruptions, lichenoid eruptions, fixed drug rash and cutaneous vasculitis. 7 Lesions may appear suddenly and enlarge rapidly. Purpuric papules, plaques, hemorrhagic bullae and even midline destruction have also been reported. [7] [8] [9] In the cocaine -levamisole cutaneous vasculopathy syndrome, lesions frequently have a distinctive morphology; they tend to be stellate with a bright erythematous border and necrotic appearing center. 1, 10 One of the most unique features of this syndrome is that the rash has a predilection for the ears which has been documented in many case reports and case series. 2, 3, 8, 11, 12 It is interesting to speculate on the reason why the ears are preferentially involved. It may be due to the fact that the lower temperature of the ear may facilitate the deposition of ANCA-associated vasculitis has been linked to various drugs, such as hydralazine, propylthiouracil and minocycline. 19 Immunologic abnormalities found in drug-induced ANCAassociated vasculitis include high titer anti-MPO antibodies or combined positivity of both anti-MPO and anti-PR3, ANA, and anti-cardiolipin antibodies, similar to that observed in cocainelevamisole cutaneous vasculopathy. 19 Typically, a prolonged exposure to a causative drug is required before the development of drug-induced autoantibody production. Rongioletti et al.
documented a mean latency of 24 months of exposure to levamisole prior to the development of circulating antibodies. 7 ANCA and anti-phospholipid antibodies induced by levamisole exposure normalize within 2 to 14 months after discontinuation of the drug. 7 The association of levamisole with leukopenia and agranulocytosis in the treatment of autoimmune disorders and cancer has been well documented. 20 Similarly, there have been multiple reports of leukopenia and agranulocytosis secondary to the use of cocaine contaminated with levamisole. [21] [22] [23] [24] Gross et al. reported that 10 out of 16 patients (63%) with this syndrome had either leukopenia with WBC count less than 4,000 per mm 3 or neutropenia with ANC less than 1,500 per mm
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Presently, it is unclear why this syndrome develops in certain cocaine users. It has been postulated that the presence of 6-phenyl-2, 3-dihydroximidazo(2,1b)-thiazole, one of the three breakdown products of levamisole, with lymphocyte-stimulating effects, could play a role in pathogenesis. 14, 25 An association between levamisole-induced agranulocytosis and HLA-B27 positivity has also been documented. 26 Currently, there is no consensus on the treatment of cocaine -levamisole cutaneous vasculopathy syndrome. It is unclear whether steroids offer any benefit, and their use must be balanced against side effects. 1 The role of other immunosuppressants is also controversial, especially when patients present with leukopenia or agranulocytosis. 16 As with other druginduced vasculitides, resolution can be hastened by withdrawing the offending drug. Recurrent skin lesions do occur when patients are re-challenged with levamisole-adulterated cocaine.
17
Recurrent lesions on re-challenge was noted in our patient; purpuric lesions on the earlobes and knees recurred after re-using cocaine (Figure 1 ).
SUMMARY
We present a case of cutaneous vasculopathy associated with levamisole-adulterated cocaine as manifested by a stellate purpuric rash with involvement of the ears and leukopenia.
Levamisole was detected in the urine and ANCA positivity was present. Pathologic findings, including microthrombi and epidermal necrosiswere also consistent with the clinical diagnosis.
Cutaneous vasculopathy associated with levamisole-adulterated cocaine, a recently described clinical entity, is characterized by a purpuric rash in a retiform pattern, with predilection for the ears, leukopenia, and ANCA positivity. This syndrome may be difficult to distinguish from a true 
